Filing Flows › America Great Health (AAGH) › Q2 FY26 › vs Q2 FY25
America Great Health (AAGH) Q2 FY26 vs Q2 FY25 (year over year)
America Great Health's revenue fell $46K (-50%) from $91K in Q2 FY25 to $45K in Q2 FY26. The biggest changes: Anti Aging Immune Support −$57K (-68%); Targeted System Support +$7K (+88%); Herbal Insulin Support +$4K (—).
America Great Health, Q2 FY26: revenue $45K (-50% year over year), operating margin -440.7%, net earnings $1.1M, operating cash flow −$126K. The chart draws each line against Q2 FY25, the increases inside each band.
Every line
| Line | Q2 FY26 | Q2 FY25 | Change | % |
|---|---|---|---|---|
| Anti Aging Immune Support | $27K | $83K | −$57K | -68% |
| Targeted System Support | $14K | $8K | $7K | +88% |
| Herbal Insulin Support | $4K | $0 | $4K | — |
| Revenue | $45K | $91K | −$46K | -50% |
| Other income, net | $1.3M | −$73K | $1.4M | — |
| Costs & expenses | $1.4M | $285K | $1.1M | +377% |
| Operating costs | $244K | $211K | $32K | +15% |
| Net earnings | $1.1M | −$194K | $1.3M | — |
| Cost of revenue | $9K | $8K | $1K | +9% |
| Operating expenses | $235K | $204K | $32K | +16% |
| Operating cash sources | $1.2M | −$279K | $1.5M | — |
| Depreciation | $4K | $4K | $0 | 0% |
| Cash used in operations | $126K | −$89K | $215K | — |
| Working capital & other | $1.2M | −$279K | $1.5M | — |
Questions
How much did America Great Health's revenue grow year over year in Q2 FY26?
America Great Health's revenue fell $46K (-50%) from $91K in Q2 FY25 to $45K in Q2 FY26.
What drove America Great Health's revenue change in Q2 FY26?
Anti Aging Immune Support −$57K (-68%); Targeted System Support +$7K (+88%); Herbal Insulin Support +$4K (—).